TABLE 1.
Characteristics of subjects included in the study
| Patient | Origin | Age (yr) | Viral load (copies/ml) | Therapy | HIV-1 subtyping
|
HLA typing
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LTRb | Gag | Pol | Nef | Env | HLA-A | HLA-B | HLA-Cw | |||||
| M12653 | Rwanda | 26 | 103 | AZT,ddCa | A | A | A | A | A | A36, A74 | B53, B58 | W4, W6 |
| M12453 | Ghana | 34 | 102 | AZT | G | A | G | AG | A | A2, A30 | B27, B50 | W2, W6 |
| M11306 | Kenya | 33 | 104 | C | C | C | C | ND | A23, A23 | B53, B58 | W4, W7 | |
| M12003 | Ethiopia | 36 | 104 | C | C | C | C | ND | A1, A30 | B7, B41 | W7, W17 | |
| M11814 | DRCa | 24 | 105 | D | D | D | F | F | A23, A24 | B35, B58 | W4, W7 | |
| M12020 | DRC | 36 | 104 | AZT | D | D | D | NDd | D | A23, A34 | B44, B53 | W4, W6 |
| M12259 | DRC | 50 | 105 | F | D | D | ND | F | A1, A1 | B8, B55 | W3, W7 | |
| M12115 | Tanzania | 43 | 106 | D | D | D | ND | ND | A1, A24 | B8, B35 | W4, W7 | |
| M12101 | Brazil | 29 | 102 | F | F | F | F | F | A3, A24 | B52, B58 | W3, W6 | |
| M13371 | Nigeria | 34 | 102 | G | G | G | G | ND | A2, A36 | B45, B58 | W3, W6 | |
a
DRC, Democratic Republic of the Congo.
b
LTR, long terminal repeat.
c
AZT, zidovudine; ddC, dideoxycytosine.
d
ND, not done.